PubMed HealthSearch

PubMed · 7489840

Visual evoked potentials in NIDDM: a longitudinal study.

Abstract

In order to assess the possible progression of neurological abnormalities over time and the value of visual evoked potential alterations in predicting stability and severity of diabetes-related optic pathway disease, a longitudinal study in non-insulin-dependent diabetic patients was performed. Neurological examination, visual evoked potentials with pattern reversal, motor and sensory nerve conduction velocities and metabolic control were studied in 18 non-insulin-dependent diabetic patients and in 35 normal control subjects at baseline and again after 4.6 +/- 0.8 years (range 4-6). At the first recording the peak P100 wave latencies were significantly delayed in the diabetic patients compared with the control subjects; signs of peripheral neuropathy were detected in five patients, clinical in three and in two there was only neurophysiological alteration without clinical signs. The second recording revealed no significant alterations of P100 latencies in patients compared with baseline, but the number with clinical signs and/or neurophysiological alterations with no clinical signs of peripheral neurological disease was increased to seven. In conclusion, we observed that visual evoked potential alterations were stable over time whereas peripheral neurological disease progressed and correlated positively with metabolic control.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G Moreo, E Mariani, G Pizzamiglio, G B Colucci. 1995. Visual evoked potentials in NIDDM: a longitudinal study.. https://doi.org/10.1007/bf00400726

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Potential gain in efficiency and power to detect gene-environment interactions by matching in case-control studies.

BACKGROUND: There is growing interest in interactions between genetic and environmental risk factors of disease, but adequate power to detect such interactions in epidemiologic studies is of concern. The aim of this paper is to quantify the effect of matching on the efficiency of estimation and power to detect gene-environment interactions in case-control studies. METHODS: Starting from an empirical example in cancer epidemiology, we simulated frequency matched and unmatched case-control studies for a wide range of assumptions regarding the prevalence and the effects of an environmental and a genetic factor on disease risk as well as the quality and quantity of the interaction between these factors. Simulated studies were analyzed with multivariable logistic regression. RESULTS: Matching increased the efficiency and power in most scenarios. The gain was most pronounced in scenarios assuming a low prevalence of the environmental exposure. In such scenarios, equivalent power was only obtained with more than twice as many unmatched than matched controls. CONCLUSIONS: Frequency matching for known environmental risk factors with a low prevalence in the population may increase the efficiency of estimation and power of case-control studies to detect gene-environment interactions considerably. Investigators should weigh the gain in efficiency and power against known potential disadvantages of matching.

Case-Control Studies

Is lipoprotein(a)-cholesterol a better predictor of vascular disease events than total lipoprotein(a) mass? A nested case control study from the West of Scotland Coronary Prevention Study.

The clinical utility of a new assay for plasma lipoprotein(a)-cholesterol (Lp(a)-C) was assessed in parallel with our routine Lp(a) mass measurements in a nested-case control study of subjects within the placebo arm of the West of Scotland Coronary Prevention Study (WOSCOPS). A total of 238 control patients and 108 patients who had suffered a serious vascular event during the course of the WOSCOPS were examined. Lp(a) mass was assessed within 2 years of sampling by an ELISA method on baseline EDTA plasma samples which had been stored at -70 degrees C. Subsequently, the Lp(a) mass was re-measured by an immunoturbidimetric assay approximately 8 years after sampling. On the same stored aliquot the Lp(a)-C was measured. These analyses allowed us to assess whether the Lp(a)-C assay could provide any additional information over and above that which would be obtained from our Lp(a) mass assays. In addition the apo(a) isoform sizes of these subjects were measured using a high resolution immunoblotting system. The Lp(a)-C and Lp(a) mass measurements provided exactly the same information in the study, as they were equally non-discriminatory between cases and controls. The only difference between the two patient groups was the percentage of 'null' apo(a) alleles (control: 25.6% versus cases: 19.4%). We conclude that these results reinforce the concordance of the two assay systems and confirm that the Lp(a)-C assay provides no added information over and above that gained from traditional Lp(a) mass assays, which may be faster and less expensive.

Case-Control Studies

Heterogeneous virulence of enteroaggregative Escherichia coli strains isolated from children in Southwest Nigeria.

Enteroaggregative Escherichia coli (EAEC) has been implicated in acute and persistent diarrhea, and most strains harbor a member of a partially-conserved plasmid family (called pAA). We studied EAEC isolated from Nigerian children aged <5 years to elucidate the roles of plasmid and chromosomal EAEC loci. We tested a total of 131 EAEC strains isolated from acute diarrhea case patients and control subjects for hybridization with 8 pAA plasmid-derived and 2 chromosomal gene probes, for several in vitro phenotypes and for resistance to antimicrobial agents. Using by multiple logistic regression, we found genes encoding the AAF/II fimbriae to be strongly associated with diarrhea in this population. EAEC strains appear to be of heterogeneous virulence, and data suggest that AAF/II may be a marker for pathogenic strains.

Case-Control Studies